46V-24121-76800
3 vaccinations
6 coded responses
25 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 176 / PA
- Registered
- 2021-05-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-30
Dose 1 — Pfizer-BioNTech
-
2021-05-21
Dose 2 — Pfizer-BioNTech
-
2021-05-23
Registered in v-safe
-
2021-05-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-05-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-05-25
Survey response — days 1–6 daily, dose 2MedDRA: Chromaturia — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Yellow-green urine output each day since dose 2.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-05-28
- 2021-06-07
- 2021-06-14
- 2021-06-20
-
2021-07-02
Survey response — day 42, dose 2MedDRA: Dry skin, Pruritus, Rash, Self-medication — Feeling: FairFree text: Itchy, dry skin rash on hands/wrist since March has worsened. Topical steroids have helped a little.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-21
-
2021-11-21
Survey response — 6 months, dose 2MedDRA: Inflammation, Pre-existing disease, Rash, Rash pruritic, Respiratory tract congestion, Sneezing — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: #NAME?MedDRA releases: 2024-11 · check-in free text available
-
2021-11-21
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-24
- 2022-05-23
-
2022-06-06
Dose 3 — Moderna
-
2022-06-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-08
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Electric shock sensation — Feeling: Fair · Site: Pain · Muscle or body aches, Rash, not including the immediate area around the injection siteFree text: Dizziness/ brain zaps (similar to those experienced with SSRI withdrawal)MedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2022-06-11
- 2022-06-14
- 2022-06-20
- 2022-06-27
- 2022-07-04
- 2022-07-11
- 2022-07-18
-
2022-09-05
Survey response — 3 months, dose 3MedDRA: Condition aggravated, Nasopharyngitis, Pre-existing disease, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Allergy/ sneeze attack for one day last month and the month before, and a minor summer head cold. I have experienced these "sneeze attacks" once or twice a season over the past few years but has gotten slightly worse (unsure of cause).MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Survey response — 6 months, dose 3MedDRA: Asthenia, Cough, Pain, Pyrexia, Rales, SARS-CoV-2 test positive, Secretion discharge, Sneezing, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Wet cough, crackling/wheezing sound in lungs, sneezy and mucous-y, achey and weak, feverish, tested positive for COVID.MedDRA releases: 2024-11 · check-in free text available
- 2023-06-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-30 | Pfizer-BioNTech | |
| 2 | 2021-05-21 | Pfizer-BioNTech | |
| 3 | 2022-06-06 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Yellow-green urine output each day since dose 2.
Release 9 — day 42, dose 2
Symptoms: Itchy, dry skin rash on hands/wrist since March has worsened. Topical steroids have helped a little.
Release 10 — 6 months, dose 2
Symptoms: #NAME?
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness/ brain zaps (similar to those experienced with SSRI withdrawal)
Release 12 — 3 months, dose 3
Symptoms: Allergy/ sneeze attack for one day last month and the month before, and a minor summer head cold. I have experienced these "sneeze attacks" once or twice a season over the past few years but has gotten slightly worse (unsure of cause).
Release 12 — 6 months, dose 3
Symptoms: Wet cough, crackling/wheezing sound in lungs, sneezy and mucous-y, achey and weak, feverish, tested positive for COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dry skin | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rales | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Chromaturia | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Electric shock sensation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release